Medtronic, Philips Offer Observations On AED Oversight
This article was originally published in The Gray Sheet
Executive Summary
The required pre-approval FDA inspections for Class III devices add "no additional value" to FDA's regulatory oversight of automated external defibrillators, Medtronic says in written comments to the agency